International Patent: N-(4-(1H-BENZO[D[IMIDAZOL-6-YL)-PYRIDIN-2-YL)BENZAMIDE DERIVATIVES AS CAMK2 INHIBITORS FOR THE TREATMENT OF HEART FAILURE

GENEVA, June 19 -- BRISTOL-MYERS SQUIBB COMPANY filed a patent application (US2025/055725) for “N-(4-(1H-BENZO[D[IMIDAZOL-6-YL)-PYRIDIN-2-YL)BENZAMIDE DERIVATIVES AS CAMK2 INHIBITORS FOR THE TREATMENT OF HEART FAILURE”. With publication no. WO/2026/107418, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61P 3/10

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....